Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardinal Buying Boron LePore, Highlights Pre-Launch Market Development

Executive Summary

Cardinal Health is highlighting Boron LePore's pre-launch market development activities and relationships with smaller pharma/biotech firms as key assets in the proposed $194 mil. acquisition of the marketing services company

You may also be interested in...



Cardinal To Run Xigris Emergency Distribution Via Acquisition Of Syncor

Cardinal will be the emergency supplier of Lilly's sepsis agent Xigris following the wholesaler's acquisition of the nuclear pharmacy company Syncor

Cardinal To Run Xigris Emergency Distribution Via Acquisition Of Syncor

Cardinal will be the emergency supplier of Lilly's sepsis agent Xigris following the wholesaler's acquisition of the nuclear pharmacy company Syncor

AdvancePCS Acquisitions To Focus On Disease Management; VP Heads Effort

AdvancePCS' acquisition strategy will focus on disease management solutions that can be cross-marketed with existing products, CEO David Halbert told analysts on the PBM's year-end conference call

Related Content

UsernamePublicRestriction

Register

PS039892

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel